1	Impaired	Impaired	B-NP	JJ	O	5	NMOD	0
2	coronary	coronary	I-NP	JJ	O	5	NMOD	-1
3	collateral	collateral	I-NP	NN	O	5	NMOD	-1
4	vessel	vessel	I-NP	NN	O	5	NMOD	-1
5	development	development	I-NP	NN	O	0	ROOT	2	development
6	in	in	B-PP	IN	O	5	NMOD	-1
7	patients	patient	B-NP	NNS	O	6	PMOD	-1
8	with	with	B-PP	IN	O	7	NMOD	-1
9	proliferative	proliferative	B-NP	JJ	O	11	NMOD	0
10	diabetic	diabetic	I-NP	JJ	O	11	NMOD	-1
11	retinopathy	retinopathy	I-NP	NN	O	8	PMOD	-1
12	.	.	O	.	O	5	P	-1

1	BACKGROUND	BACKGROUND	B-NP	NN	O	0	ROOT	-1
2	:	:	O	:	O	1	P	-1
3	Diabetic	Diabetic	B-NP	JJ	O	4	NMOD	-1
4	patients	patient	I-NP	NNS	O	5	SUB	-1
5	have	have	B-VP	VBP	O	1	NMOD	-1
6	been	be	I-VP	VBN	O	5	VC	-1
7	reported	report	I-VP	VBN	O	6	VC	-1
8	to	to	I-VP	TO	O	9	VMOD	-1
9	have	have	I-VP	VB	O	7	VMOD	-1
10	impaired	impair	I-VP	VBN	O	9	VMOD	0
11	coronary	coronary	B-NP	JJ	O	14	NMOD	-1
12	collateral	collateral	I-NP	NN	O	14	NMOD	-1
13	vessel	vessel	I-NP	NN	O	14	NMOD	-1
14	growth	growth	I-NP	NN	O	10	OBJ	4	growth
15	,	,	O	,	O	5	P	-1
16	although	although	B-SBAR	IN	O	5	VMOD	-1
17	they	they	B-NP	PRP	O	18	SUB	-1
18	have	have	B-VP	VBP	O	16	SBAR	-1
19	excessive	excessive	B-NP	JJ	O	20	NMOD	-1
20	neovascularization	neovascularization	I-NP	NN	O	18	OBJ	3	neovascularization
21	in	in	B-PP	IN	O	18	VMOD	-1
22	the	the	B-NP	DT	O	23	NMOD	-1
23	retina	retina	I-NP	NN	O	21	PMOD	-1
24	.	.	O	.	O	1	P	-1

1	HYPOTHESIS	HYPOTHESIS	B-NP	NN	O	4	NMOD	-1
2	:	:	O	:	O	1	P	-1
3	This	This	B-NP	DT	O	4	NMOD	-1
4	study	study	I-NP	NN	O	5	SUB	-1
5	was	be	B-VP	VBD	O	0	ROOT	-1
6	designed	design	I-VP	VBN	O	5	VC	-1
7	to	to	B-VP	TO	O	8	VMOD	-1
8	compare	compare	I-VP	VB	O	6	VMOD	-1
9	coronary	coronary	B-NP	JJ	O	11	NMOD	-1
10	collateral	collateral	I-NP	NN	O	11	NMOD	-1
11	circulation	circulation	I-NP	NN	O	8	OBJ	-1
12	(	(	O	(	O	14	DEP	-1
13	CCC	CCC	B-NP	NN	O	14	DEP	-1
14	)	)	O	)	O	11	NMOD	-1
15	in	in	B-PP	IN	O	11	NMOD	-1
16	patients	patient	B-NP	NNS	O	15	PMOD	-1
17	with	with	B-PP	IN	O	16	NMOD	-1
18	proliferative	proliferative	B-NP	JJ	O	20	NMOD	0
19	diabetic	diabetic	I-NP	JJ	O	20	NMOD	-1
20	retinopathy	retinopathy	I-NP	NN	O	17	PMOD	-1
21	(	(	O	(	O	23	DEP	-1
22	PDR	PDR	B-NP	NN	B-protein	23	DEP	-1
23	)	)	O	)	O	20	NMOD	-1
24	with	with	B-PP	IN	O	16	NMOD	-1
25	that	that	B-NP	DT	O	24	PMOD	-1
26	in	in	B-PP	IN	O	25	NMOD	-1
27	patients	patient	B-NP	NNS	O	26	PMOD	-1
28	without	without	B-PP	IN	O	27	NMOD	-1
29	DR	DR	B-NP	NN	B-protein	28	PMOD	-1
30	.	.	O	.	O	5	P	-1

1	METHODS	METHODS	B-NP	NNS	O	0	ROOT	-1
2	:	:	O	:	O	1	P	-1
3	Ninety	Ninety	B-NP	CD	O	5	NMOD	-1
4	diabetic	diabetic	I-NP	JJ	O	5	NMOD	-1
5	patients	patient	I-NP	NNS	O	18	SUB	-1
6	with	with	B-PP	IN	O	5	NMOD	-1
7	chronic	chronic	B-NP	JJ	O	9	NMOD	-1
8	total	total	I-NP	JJ	O	9	NMOD	-1
9	occlusion	occlusion	I-NP	NN	O	6	PMOD	-1
10	in	in	B-PP	IN	O	5	NMOD	-1
11	at	at	B-NP	IN	O	14	NMOD	-1
12	least	least	I-NP	JJS	O	11	AMOD	-1
13	one	one	I-NP	CD	O	11	AMOD	-1
14	major	major	I-NP	JJ	O	10	PMOD	-1
15	epicardial	epicardial	I-NP	JJ	O	17	NMOD	-1
16	coronary	coronary	I-NP	JJ	O	17	NMOD	-1
17	artery	artery	I-NP	NN	O	14	NMOD	-1
18	were	be	B-VP	VBD	O	1	NMOD	-1
19	enrolled	enrol	I-VP	VBN	O	18	VC	-1
20	in	in	B-PP	IN	O	19	VMOD	-1
21	the	the	B-NP	DT	O	22	NMOD	-1
22	study	study	I-NP	NN	O	20	PMOD	-1
23	.	.	O	.	O	1	P	-1

1	Groups	Group	B-NP	NNS	O	5	SUB	-1
2	1	1	I-NP	CD	O	4	NMOD	-1
3	and	and	I-NP	CC	O	4	NMOD	-1
4	2	2	I-NP	CD	O	1	NMOD	-1
5	consisted	consist	B-VP	VBD	O	0	ROOT	-1
6	of	of	B-PP	IN	O	5	VMOD	-1
7	48	48	B-NP	CD	O	8	NMOD	-1
8	patients	patient	I-NP	NNS	O	6	PMOD	-1
9	without	without	B-PP	IN	O	5	VMOD	-1
10	DR	DR	B-NP	NN	O	13	NMOD	-1
11	and	and	O	CC	O	13	NMOD	-1
12	42	42	B-NP	CD	O	13	NMOD	-1
13	patients	patient	I-NP	NNS	O	9	PMOD	-1
14	with	with	B-PP	IN	O	13	NMOD	-1
15	PDR	PDR	B-NP	NN	O	14	PMOD	-1
16	,	,	O	,	O	5	P	-1
17	respectively	respectively	B-ADVP	RB	O	5	VMOD	-1
18	.	.	O	.	O	5	P	-1

1	Coronary	Coronary	B-NP	JJ	O	3	NMOD	-1
2	collateral	collateral	I-NP	NN	O	3	NMOD	-1
3	circulation	circulation	I-NP	NN	O	7	SUB	-1
4	(	(	O	(	O	6	DEP	-1
5	CCC	CCC	B-NP	NN	O	6	DEP	-1
6	)	)	O	)	O	3	NMOD	-1
7	was	be	B-VP	VBD	O	0	ROOT	-1
8	analyzed	analyze	I-VP	VBN	O	7	VC	-1
9	according	accord	B-PP	VBG	O	8	VMOD	-1
10	to	to	B-PP	TO	O	9	PMOD	-1
11	the	the	B-NP	DT	O	13	NMOD	-1
12	Rentrop	Rentrop	I-NP	NNP	O	13	NMOD	-1
13	system	system	I-NP	NN	O	10	PMOD	0
14	.	.	O	.	O	7	P	-1

1	Each	Each	B-NP	DT	O	2	NMOD	-1
2	group	group	I-NP	NN	O	3	SUB	-1
3	was	be	B-VP	VBD	O	0	ROOT	-1
4	also	also	I-VP	RB	O	3	VMOD	-1
5	divided	divide	I-VP	VBN	O	3	VC	-1
6	into	into	B-PP	IN	O	5	VMOD	-1
7	two	two	B-NP	CD	O	8	NMOD	-1
8	subgroups	subgroup	I-NP	NNS	O	6	PMOD	-1
9	according	accord	B-PP	VBG	O	8	NMOD	-1
10	to	to	B-PP	TO	O	9	PMOD	-1
11	poor	poor	B-NP	JJ	O	14	NMOD	-1
12	and	and	I-NP	CC	O	14	NMOD	-1
13	good	good	I-NP	JJ	O	14	NMOD	-1
14	CCC	CCC	I-NP	NN	O	10	PMOD	-1
15	.	.	O	.	O	3	P	-1

1	Serum	Serum	B-NP	NN	B-protein	5	NMOD	-1
2	vascular	vascular	I-NP	JJ	I-protein	5	NMOD	-1
3	endothelial	endothelial	I-NP	JJ	I-protein	5	NMOD	-1
4	growth	growth	I-NP	NN	I-protein	5	NMOD	0
5	factor	factor	I-NP	NN	I-protein	9	NMOD	-1
6	(	(	O	(	O	8	DEP	-1
7	VEGF	VEGF	B-NP	NN	B-protein	8	DEP	-1
8	)	)	O	)	O	5	NMOD	-1
9	levels	level	B-NP	NNS	O	10	SUB	-1
10	were	be	B-VP	VBD	O	0	ROOT	-1
11	measured	measure	I-VP	VBN	O	10	VC	-1
12	using	use	B-VP	VBG	O	10	VMOD	-1
13	the	the	B-NP	DT	O	16	NMOD	-1
14	enzyme-linked	enzyme-linked	I-NP	JJ	O	16	NMOD	-1
15	immunosorbent	immunosorbent	I-NP	JJ	O	16	NMOD	-1
16	assay	assay	I-NP	NN	O	20	NMOD	-1
17	(	(	O	(	O	19	DEP	-1
18	ELISA	ELISA	B-NP	NN	O	19	DEP	-1
19	)	)	O	)	O	16	NMOD	-1
20	kit	kit	B-NP	NN	O	12	OBJ	-1
21	.	.	O	.	O	10	P	-1

1	RESULTS	RESULTS	B-NP	NNS	O	0	ROOT	0
2	:	:	O	:	O	1	P	-1
3	The	The	B-NP	DT	O	7	NMOD	-1
4	mean	mean	I-NP	JJ	O	7	NMOD	-1
5	Rentrop	Rentrop	I-NP	NNP	O	7	NMOD	-1
6	collateral	collateral	I-NP	NN	O	7	NMOD	-1
7	score	score	I-NP	NN	O	8	SUB	-1
8	was	be	B-VP	VBD	O	1	NMOD	-1
9	higher	high	B-ADJP	JJR	O	8	PRD	-1
10	in	in	B-PP	IN	O	9	AMOD	-1
11	Group	Group	B-NP	NN	O	10	PMOD	-1
12	1	1	I-NP	CD	O	11	NMOD	-1
13	than	than	B-PP	IN	O	9	AMOD	-1
14	in	in	B-PP	IN	O	13	PMOD	-1
15	Group	Group	B-NP	NN	O	14	PMOD	-1
16	2	2	I-NP	CD	O	15	NMOD	-1
17	(	(	O	(	O	32	DEP	-1
18	2.39	2.39	B-NP	CD	O	24	NMOD	-1
19	+/-	+/-	O	SYM	O	24	NMOD	-1
20	1.07	1.07	B-NP	CD	O	24	NMOD	-1
21	vs.	vs.	B-PP	IN	O	24	NMOD	-1
22	1.76	1.76	B-NP	CD	O	24	NMOD	-1
23	+/-	+/-	I-NP	SYM	O	24	NMOD	-1
24	0.76	0.76	I-NP	CD	O	28	NMOD	-1
25	,	,	O	,	O	24	P	-1
26	respectively	respectively	B-ADVP	RB	O	24	NMOD	-1
27	,	,	O	,	O	28	P	-1
28	p	p	B-NP	NN	O	32	DEP	-1
29	less	less	B-ADJP	JJR	O	28	NMOD	-1
30	than	than	B-PP	IN	O	29	AMOD	-1
31	0.001	0.001	B-NP	CD	O	30	PMOD	-1
32	)	)	O	)	O	9	AMOD	-1
33	.	.	O	.	O	1	P	-1

1	When	When	B-ADVP	WRB	O	17	VMOD	-1
2	the	the	B-NP	DT	O	4	NMOD	-1
3	two	two	I-NP	CD	O	4	NMOD	-1
4	groups	group	I-NP	NNS	O	5	SUB	-1
5	were	be	B-VP	VBD	O	1	SBAR	-1
6	compared	compare	I-VP	VBN	O	5	VC	-1
7	with	with	B-PP	IN	O	6	VMOD	-1
8	respect	respect	B-NP	NN	O	7	PMOD	-1
9	to	to	B-PP	TO	O	8	NMOD	-1
10	poor	poor	B-NP	JJ	O	12	AMOD	-1
11	and	and	I-NP	CC	O	12	AMOD	-1
12	good	good	I-NP	JJ	O	16	NMOD	-1
13	CCC	CCC	I-NP	NN	O	16	NMOD	-1
14	,	,	O	,	O	16	P	-1
15	poor	poor	B-NP	JJ	O	16	NMOD	-1
16	CCC	CCC	I-NP	NN	O	9	PMOD	-1
17	was	be	B-VP	VBD	O	0	ROOT	-1
18	higher	high	B-ADJP	JJR	O	17	PRD	-1
19	in	in	B-PP	IN	O	18	AMOD	-1
20	patients	patient	B-NP	NNS	O	19	PMOD	-1
21	with	with	B-PP	IN	O	20	NMOD	-1
22	PDR	PDR	B-NP	NN	O	21	PMOD	-1
23	(	(	O	(	O	34	DEP	-1
24	64	64	B-NP	CD	O	27	NMOD	-1
25	vs.	vs.	B-PP	IN	O	27	NMOD	-1
26	36	36	B-NP	CD	O	27	NMOD	-1
27	%	%	I-NP	NN	O	34	DEP	-1
28	,	,	O	,	O	27	P	-1
29	respectively	respectively	B-ADVP	RB	O	27	NMOD	-1
30	,	,	O	,	O	34	P	-1
31	p	p	B-NP	NN	O	34	DEP	-1
32	=	=	B-VP	SYM	O	31	NMOD	-1
33	0.01	0.01	B-NP	CD	O	32	AMOD	-1
34	)	)	O	)	O	22	NMOD	-1
35	.	.	O	.	O	17	P	-1

1	Serum	Serum	B-NP	NN	B-protein	3	NMOD	-1
2	VEGF	VEGF	I-NP	NN	I-protein	3	NMOD	-1
3	levels	level	I-NP	NNS	O	4	SUB	-1
4	were	be	B-VP	VBD	O	39	VMOD	-1
5	higher	high	B-ADJP	JJR	O	4	PRD	-1
6	in	in	B-PP	IN	O	5	AMOD	-1
7	patients	patient	B-NP	NNS	O	6	PMOD	-1
8	with	with	B-PP	IN	O	7	NMOD	-1
9	PDR	PDR	B-NP	NN	B-protein	8	PMOD	-1
10	than	than	B-PP	IN	O	5	AMOD	-1
11	in	in	B-PP	IN	O	10	PMOD	-1
12	those	those	B-NP	DT	O	11	PMOD	-1
13	without	without	B-PP	IN	O	12	NMOD	-1
14	DR	DR	B-NP	NN	O	13	PMOD	-1
15	(	(	O	(	O	29	DEP	-1
16	219	219	B-NP	CD	O	18	AMOD	-1
17	+/-	+/-	I-NP	SYM	O	18	AMOD	-1
18	99	99	I-NP	CD	O	23	NMOD	-1
19	vs.	vs.	B-PP	IN	O	23	NMOD	-1
20	139	139	B-NP	CD	O	22	AMOD	-1
21	+/-	+/-	I-NP	SYM	O	22	AMOD	-1
22	98	98	I-NP	CD	O	23	NMOD	-1
23	pg/ml	pg/ml	I-NP	NN	O	25	NMOD	-1
24	,	,	O	,	O	25	P	-1
25	p	p	B-NP	NN	O	27	SUB	-1
26	less	less	B-ADJP	JJR	O	27	AMOD	-1
27	than	than	B-PP	IN	O	29	DEP	-1
28	0.001	0.001	B-NP	CD	O	27	AMOD	-1
29	)	)	O	)	O	12	NMOD	-1
30	;	;	O	:	O	39	P	-1
31	however	however	B-ADVP	RB	O	39	VMOD	-1
32	,	,	O	,	O	39	P	-1
33	patients	patient	B-NP	NNS	O	39	SUB	-1
34	with	with	B-PP	IN	O	33	NMOD	-1
35	poor	poor	B-NP	JJ	O	37	AMOD	-1
36	and	and	I-NP	CC	O	37	AMOD	-1
37	good	good	I-NP	JJ	O	38	NMOD	-1
38	CCC	CCC	I-NP	NN	O	34	PMOD	-1
39	had	have	B-VP	VBD	O	0	ROOT	-1
40	similar	similar	B-NP	JJ	O	42	NMOD	-1
41	VEGF	VEGF	I-NP	NN	B-protein	42	NMOD	-1
42	levels	level	I-NP	NNS	O	39	OBJ	-1
43	.	.	O	.	O	39	P	-1

1	CONCLUSIONS	CONCLUSIONS	B-NP	NNS	O	0	ROOT	-1
2	:	:	O	:	O	1	P	-1
3	We	We	B-NP	PRP	O	4	SUB	-1
4	have	have	B-VP	VBP	O	1	NMOD	-1
5	shown	show	I-VP	VBN	O	4	VC	-1
6	that	that	B-SBAR	IN	O	5	VMOD	-1
7	patients	patient	B-NP	NNS	O	10	SUB	-1
8	with	with	B-PP	IN	O	7	NMOD	-1
9	PDR	PDR	B-NP	NN	B-protein	8	PMOD	-1
10	have	have	B-VP	VBP	O	6	SBAR	-1
11	a	a	B-NP	DT	O	15	NMOD	-1
12	lower	low	I-NP	JJR	O	15	NMOD	-1
13	coronary	coronary	I-NP	JJ	O	15	NMOD	-1
14	collateral	collateral	I-NP	NN	O	15	NMOD	-1
15	score	score	I-NP	NN	O	10	OBJ	-1
16	than	than	B-PP	IN	O	15	NMOD	-1
17	patients	patient	B-NP	NNS	O	16	PMOD	-1
18	without	without	B-PP	IN	O	17	NMOD	-1
19	DR	DR	B-NP	NN	B-protein	18	PMOD	-1
20	.	.	O	.	O	1	P	-1

1	Also	Also	B-ADVP	RB	O	5	VMOD	-1
2	,	,	O	,	O	5	P	-1
3	serum	serum	B-NP	NN	B-protein	4	NMOD	-1
4	VEGF	VEGF	I-NP	NN	I-protein	5	SUB	-1
5	was	be	B-VP	VBD	O	0	ROOT	-1
6	significantly	significantly	B-ADJP	RB	O	7	AMOD	-1
7	higher	high	I-ADJP	JJR	O	5	PRD	-1
8	in	in	B-PP	IN	O	7	AMOD	-1
9	patients	patient	B-NP	NNS	O	8	PMOD	-1
10	with	with	B-PP	IN	O	9	NMOD	-1
11	PDR	PDR	B-NP	NN	B-protein	10	PMOD	-1
12	than	than	B-PP	IN	O	7	AMOD	-1
13	in	in	B-PP	IN	O	12	PMOD	-1
14	those	those	B-NP	DT	O	13	PMOD	-1
15	without	without	B-PP	IN	O	14	NMOD	-1
16	DR	DR	B-NP	NN	B-protein	15	PMOD	-1
17	.	.	O	.	O	5	P	-1

1	These	These	B-NP	DT	O	2	NMOD	-1
2	findings	finding	I-NP	NNS	O	3	SUB	-1
3	have	have	B-VP	VBP	O	0	ROOT	-1
4	suggested	suggest	I-VP	VBN	O	3	VC	-1
5	that	that	B-SBAR	IN	O	4	VMOD	-1
6	diabetes	diabetes	B-NP	NN	O	7	NMOD	-1
7	mellitus	mellitus	I-NP	NN	O	8	SUB	-1
8	may	may	B-VP	MD	O	5	SBAR	-1
9	have	have	I-VP	VB	O	8	VC	-1
10	a	a	B-NP	DT	O	12	NMOD	-1
11	different	different	I-NP	JJ	O	12	NMOD	-1
12	action	action	I-NP	NN	O	9	OBJ	0
13	on	on	B-PP	IN	O	9	VMOD	-1
14	retinal	retinal	B-NP	JJ	O	17	NMOD	-1
15	and	and	I-NP	CC	O	17	NMOD	-1
16	coronary	coronary	I-NP	JJ	O	17	NMOD	-1
17	circulation	circulation	I-NP	NN	O	13	PMOD	-1
